A significant percentage of patients with degenerative bone diseases or traumatic bone injuries fail to heal with current technologies often leading to complicated revision surgeries, a long painful recovery process or permanent disability. Aastrom is developing Bone Repair Cells (BRCs), based on TRC technology, with the goal of promoting bone regeneration in patients for which the standard of care has previously failed or no therapeutic options exist.
|
